Terms: = Liver cancer AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869
46 results:
1. Whole-genome sequencing and RNA sequencing analysis reveals novel risk genes and differential expression patterns in hepatoblastoma.
Wang W; Zhang N; Chen L; Zhao X; Shan Y; Yang F; Wang B; Gao H; Xu M; Tang P; Qin S; Gu S
Gene; 2024 Mar; 897():147991. PubMed ID: 37972697
[TBL] [Abstract] [Full Text] [Related]
2. TC2N Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Targeting the Wnt/β-Catenin Signaling Pathway.
Lou YX; Gu J; Zhu L; Sun SQ; Hao XL; Chen JP; Han F; Wang DD; Jiang X; Liu JY
Lab Invest; 2023 Dec; 103(12):100260. PubMed ID: 37839635
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of potential targets to enhance the sensitivity of cholangiocarcinoma cells to anticancer drugs.
Sanchon-Sanchez P; Briz O; Macias RIR; Abad M; Sanchez-Martin A; Marin JJG; Lozano E
Biomed Pharmacother; 2023 Dec; 168():115658. PubMed ID: 37832404
[TBL] [Abstract] [Full Text] [Related]
4. Absent expansion of axin2+ hepatocytes and altered physiology in axin2CreERT2 mice challenges the role of pericentral hepatocytes in homeostatic liver regeneration.
May S; Müller M; Livingstone CR; Skalka GL; Walsh PJ; Nixon C; Hedley A; Shaw R; Clark W; Vande Voorde J; Officer-Jones L; Ballantyne F; Powley IR; Drake TM; Kiourtis C; Keith A; Rocha AS; Tardito S; Sumpton D; Le Quesne J; Bushell M; Sansom OJ; Bird TG
J Hepatol; 2023 May; 78(5):1028-1036. PubMed ID: 36702176
[TBL] [Abstract] [Full Text] [Related]
5. Chronic alcohol exposure induces hepatocyte damage by inducing oxidative stress, SATB2 and stem cell-like characteristics, and activating lipogenesis.
Yu W; Ma Y; Shrivastava SK; Srivastava RK; Shankar S
J Cell Mol Med; 2022 Apr; 26(7):2119-2131. PubMed ID: 35152538
[TBL] [Abstract] [Full Text] [Related]
6. Kangxianruangan granule‑containing serum mediated inhibition of hepatic oval cell differentiation into hepatocellular carcinoma cells via the Wnt‑1/β‑catenin signaling pathway.
Tang W; Xue J; Luo L; Wang Y; Cai X; Liu Y; Huang D; Wang X; He T; Lu D; Yang F
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913065
[TBL] [Abstract] [Full Text] [Related]
7. Development and validation of genomic and epigenomic signatures associated with tumor immune microenvironment in hepatoblastoma.
Zhang Y; Zhang T; Yin Q; Luo H
BMC Cancer; 2021 Oct; 21(1):1156. PubMed ID: 34711185
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of stereotactic body radiation therapy versus fractionated radiation therapy for primary liver cancer with portal vein tumor thrombus.
Zhang S; He L; Bo C; Yang S; An Y; Li N; Zhao Y; Zhao L; Ma W; Zheng Z
Radiat Oncol; 2021 Aug; 16(1):149. PubMed ID: 34391452
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of AXIN1 and axin2 as targets of tankyrase inhibition in hepatocellular carcinoma cell lines.
Wang W; Liu P; Lavrijsen M; Li S; Zhang R; Li S; van de Geer WS; van de Werken HJG; Peppelenbosch MP; Smits R
Sci Rep; 2021 Apr; 11(1):7470. PubMed ID: 33811251
[TBL] [Abstract] [Full Text] [Related]
10. Identification of novel human Wnt target genes using adult endodermal tissue-derived organoids.
Boonekamp KE; Heo I; Artegiani B; Asra P; van Son G; de Ligt J; Clevers H
Dev Biol; 2021 Jun; 474():37-47. PubMed ID: 33571486
[TBL] [Abstract] [Full Text] [Related]
11. Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133- nonstem cell population in hepatocellular carcinoma cell line, HuH-7.
Karabicici M; Alptekin S; Fırtına Karagonlar Z; Erdal E
Mol Oncol; 2021 Aug; 15(8):2185-2202. PubMed ID: 33524223
[TBL] [Abstract] [Full Text] [Related]
12. Risk of adverse events in advanced hepatocellular carcinoma with immune checkpoint therapy: A systematic review and meta-analysis.
Yuan H; Mao J; Liu C; Fu H; Guo W; Ding G
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):845-854. PubMed ID: 32307332
[TBL] [Abstract] [Full Text] [Related]
13. TM4SF1, a binding protein of DVL2 in hepatocellular carcinoma, positively regulates beta-catenin/TCF signalling.
Zhu C; Luo X; Wu J; Liu Y; Liu L; Ma S; Xie R; Wang S; Ji W
J Cell Mol Med; 2021 Mar; 25(5):2356-2364. PubMed ID: 31876386
[TBL] [Abstract] [Full Text] [Related]
14. Challenges of transarterial therapy for hepatocellular carcinoma in patients with chronic kidney disease.
Lin WC; Chang CW; Chang CW; Wang TE; Chen MJ; Wang HY
Medicine (Baltimore); 2019 Aug; 98(35):e17007. PubMed ID: 31464957
[TBL] [Abstract] [Full Text] [Related]
15. Cytotoxic activity of broussochalcone a against colon and liver cancer cells by promoting destruction complex-independent β-catenin degradation.
Shin S; Son Y; Liu KH; Kang W; Oh S
Food Chem Toxicol; 2019 Sep; 131():110550. PubMed ID: 31163223
[TBL] [Abstract] [Full Text] [Related]
16. MicroRNA-197 Promotes Metastasis of Hepatocellular Carcinoma by Activating Wnt/β-Catenin Signaling.
Hu Z; Wang P; Lin J; Zheng X; Yang F; Zhang G; Chen D; Xie J; Gao Z; Peng L; Xie C
Cell Physiol Biochem; 2018; 51(1):470-486. PubMed ID: 30453289
[TBL] [Abstract] [Full Text] [Related]
17. Oncogenic STRAP Supports Hepatocellular Carcinoma Growth by Enhancing Wnt/β-Catenin Signaling.
Wang W; Li S; Liu P; Sideras K; van de Werken HJG; van der Heide M; Cao W; Lavrijsen M; Peppelenbosch MP; Bruno M; Pan Q; Smits R
Mol Cancer Res; 2019 Feb; 17(2):521-531. PubMed ID: 30257989
[TBL] [Abstract] [Full Text] [Related]
18. Psoralen induced cell cycle arrest by modulating Wnt/β-catenin pathway in breast cancer cells.
Wang X; Xu C; Hua Y; Cheng K; Zhang Y; Liu J; Han Y; Liu S; Zhang G; Xu S; Yang Z
Sci Rep; 2018 Sep; 8(1):14001. PubMed ID: 30228287
[TBL] [Abstract] [Full Text] [Related]
19. Omega-3 polyunsaturated fatty acid inhibits the malignant progression of hepatocarcinoma by inhibiting the Wnt/β-catenin pathway.
Chang FZ; Wang Q; Zhang Q; Chang LL; Li W
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4500-4508. PubMed ID: 30058686
[TBL] [Abstract] [Full Text] [Related]
20. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
[Next]
